使用 ONT 长读序列的 APOE 单元型分期检测揭示了西班牙人口中两种常见的 ε3 和 ε4 内基单元型
Pablo García-González1,2,3, Raquel Puerta1,3, Amanda Cano1,2
1ACE Alzheimer Center Barcelona - Universitat Internacional de Catalunya, Barcelona, Spain.
medRxiv : the preprint server for health sciences
|April 8, 2025
概括
特定的阿波利波蛋白E (APOE) 基因单元类型通过调节APOE蛋白水平来影响阿尔茨海默病 (AD) 风险. 这些发现揭示了新的调节机制和AD进展的潜在治疗点.
科学领域:
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 无脂蛋白E (APOE) 基因是阿尔茨海默病 (AD) 风险的关键决定因素, ε4 基因基因显著增加了易感性.
- 在APOE ε3和 ε4背景中,不同的内基因哈普洛型配置的功能影响仍然不太清楚.
研究的目的:
- 为了研究内基APOE亚类型在调节APOE表达中的作用.
- 评估这些单元类型对阿尔茨海默病进展的影响.
主要方法:
- 利用牛津纳米孔技术 (ONT) 长读测序,在1,265个个体的APOE位点内测定相变异.
- 使用Olink平台评估脑脊液 (CSF) 中的APOE蛋白水平.
- 在使用考克斯比例危险模型的轻度认知障碍 (MCI) 患者中分析了痴呆症进展.
主要成果:
- 确定了59种独特的APOE单元型,分为五个主要单元型组 (ε2, ε3A, ε3B, ε4A, ε4B).
- ε4A单元组显著降低了脑脊液中的APOE ε4蛋白水平 (p = 0.004),可能减轻AD风险.
- 在 ε3/ε4 载体中, ε3B 单元组增加了 APOE ε3 蛋白水平 (p = 0.025),这表明它起到了补偿作用.
- 无论是 ε4A 和 ε3B 单基组,都显示出防止从MCI发展为痴呆的保护作用.
结论:
- 内基APOE单元组调节APOE的表达,并可能影响阿尔茨海默病的发病过程.
- 对于理解APOE的功能影响和开发有针对性的疗法来说,哈普洛型特异性影响至关重要.
- 对APOE locus监管网络及其相互作用的进一步研究是有必要的.
相关概念视频
RNA-seq
9.7K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
9.7K
Sanger Sequencing
751.4K
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
751.4K


